In addition, the contents of IL-10 were dramatically decreased in the Nx stage when compared to patients with N0 stage of PTC patients (Fig. 3), indicating the existence of adaptive immunity in patients with lymph node metastasis. Here, IL10 is linked to metastatic malignant neoplasm in the lymph nodes.